63793-98-6

Basic information

• Product Name: Pyridine, 2-methyl-5-(phenylmethoxy)-
• CAS NO: 63793-98-6
• Molecular Formula: C13H13NO
• Molecular Weight: 199.252
• Mol File: 63793-98-6.mol
• Article Data: 26

Chemical Properties

• CAS DataBase Reference: Pyridine, 2-methyl-5-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 2-methyl-5-(phenylmethoxy)-(63793-98-6)
• EPA Substance Registry System: Pyridine, 2-methyl-5-(phenylmethoxy)-(63793-98-6)

Safety Data

• Hazardous Substances Data: 63793-98-6(Hazardous Substances Data)

Upstream product

• 1121-78-4 5-Hydroxy-2-methylpyridine 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 

Downstream Products

• 59781-09-8 5-(benzyloxy)-2-methylpyridine 1-oxide 
• 59781-10-1 2-acetoxymethyl-5-benzyloxy pyridine 
• 648415-02-5 [1-(5-Benzyloxy-pyridin-2-yl)-meth-(E)-ylidene]-trimethylsilanyl-amine 
• 647840-12-8 (3R,4S)-4-(5-benzyloxy-2-pyridyl)-3-triisopropylsilyloxy-2-azetidinone 
• 647840-13-9 (3R,4S)-4-(5-benzyloxy-2-pyridyl)-1-(tert-butoxycarbonyl)-3-triisopropylsilyloxy-2-azetidinone 
• 647840-15-1 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-11-en-13-yl (2R,3S)-3-(5-benzyloxy-2-pyridyl)-3-(tert-butoxycarbonylamino)-2-hydroxypropionate 
• 647840-16-2 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-9,10-[(1S)-2-(morpholino)ethylidenedioxy]tax-11-en-13-yl (2R,3S)-3-(5-benzyloxy-2-pyridyl)-3-(tert-butoxycarbonylamino)-2-hydroxypropionate 
• 647840-14-0 (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-5,20-epoxy-1-hydroxy-9,10-[(1S)-2-propenylidenedioxy]tax-11-en-13-yl (2R,3S)-3-(5-benzyloxy-2-pyridyl)-3-(tert-butoxycarbonylamino)-2-triisopropylsilyloxypropionate 
• 74386-55-3 5-phenylmethoxypyridin-2-carboxylic acid 
• 262278-59-1 (S)-2-Benzenesulfonylamino-3-({4-oxo-7-[3-(pyrimidin-2-ylamino)-propoxy]-4H-quinolizine-2-carbonyl)-amino)-propionic Acid tert-butyl Ester 
• 262278-34-2 (S)-2-benzenesulfonylamino-3-{[7-(3-tert-butoxycarbonylamino-propoxy)-4-oxo-4H-quinolizine-2-carbonyl]-amino}-propionic acid tert-butyl ester 
• 262278-27-3 7-benzyloxy-4-oxo-4H-quinolizine-2-carboxylic acid methyl ester 
• 262277-51-0 (S)-3-{[7-(3-Amino-propoxy)-4-oxo-4H-quinolizine-2-carbonyl]-amino}-2-benzenesulfonylamino-propionic Acid Trifluoroacetic Acid Salt 
• 1616666-91-1 3-(benzyloxy)-2-(tert-butoxy)-6-methylpyridine 

Relevant articles and documents

Manganese-Based Contrast Agents for Magnetic Resonance Imaging of Liver Tumors: Structure-Activity Relationships and Lead Candidate Evaluation

Gd-based MRI contrast agents (GBCAs) have come under intense regulatory scrutiny due to concerns of Gd retention and delayed toxicity. Three GBCAs comprising acyclic Gd chelates, the class of GBCA most prone to Gd release, are no longer marketed in Europe

NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND

The present invention provides a compound having excellent regulating action on blood lipid level. The present invention provides a compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof, etc., wherein A represents a 5-membered nitrogen-containing aromatic heterocyclyl group; R1 represents COOH or the like; each R2 represents an alkyl or the like; each R3 represents an optionally substituted phenyl, an optionally substituted phenylalkyl, or the like; m represents 0, 1, 2, or 3; n represents 0 or 1; each of R4, R5, R6, and R7 represents H, an alkyl, or the like; and B represents an optionally substituted naphthyl, an optionally substituted aromatic heterocyclyl, or a group represented by the following formula (II) wherein each of B1 and B2 represents an optionally substituted phenyl or an optionally substituted aromatic heterocyclyl.

QUINOLINE DERIVATIVES

The invention concerns quinoline derivatives of Formula I or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.